| ADCs | antibody-drug conjugates |
| ALDH | aldehyde dehydrogenase |
| ATM | ataxia telangiectasia mutated |
| ATR | ataxia telangiectasia and Rad3-related |
| BRCA1 | breast cancer 1 |
| CAFs | cancer-associated fibroblasts |
| CC | cervical cancer |
| CCSC | cervical cancer stem cell |
| CHK1 and 2 | checkpoint kinase 1 and 2 |
| cPLA2α | cytosolic phospholipase A2alpha |
| CSC | cancer stem cell |
| DDR | DNA damage response |
| DNMTs | DNA methyltransferases |
| EMT | epithelial-mesenchymal transition |
| HBO | hyperbaric oxygen |
| HDACs | histone deacetylases |
| HPV | human papillomavirus |
| MDR | multidrug resistance |
| miRNA/miR | micro-RNA |
| MSI1 | musashi RNA binding protein 1 |
| NPs | nanoparticles |
| PARP | poly (ADP-ribose) polymerase |
| SP | Side population |
| TAMs | tumor-associated macrophages |
| TME | tumor microenvironment |